Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R N Maini

Showing results (11-20 of 337) with videos related to

Pageof 34
Sort By:
Annals of the Rheumatic Diseases|October 22, 2005
The 2005 International Symposium on Advances in Targeted Therapies: what have we learned in the 2000s and where are we going?R N Maini
Rheumatology (Oxford, England)|January 26, 2000
Workshop summary: health outcomes and health economic issues surrounding the use of biological therapies in patients with rheumatoid arthritisR N Maini, F Wolfe
Springer Seminars in Immunopathology|December 4, 1998
Rheumatoid arthritis: introductionM Feldmann, R N Maini
Lancet (London, England)|September 21, 1996
Cytokine therapy in rheumatoid arthritisR N Maini, M Feldmann
Annual Review of Immunology|March 13, 2001
Anti-TNF alpha therapy of rheumatoid arthritis: what have we learned?M Feldmann, R N Maini
International Journal of Clinical Practice|May 16, 2001
Tumour necrosis factor as a therapeutic target in rheumatoid arthritis and other chronic inflammatory diseases: the clinical experience with infliximab (REMICADE)J Bondeson, R N Maini
Rheumatology (Oxford, England)|January 26, 2000
The role of cytokines in the pathogenesis of rheumatoid arthritisM Feldmann, R N Maini
The Netherlands Journal of Medicine|January 1, 1984
Circulating immune complexes (CIC) in connective tissue diseases (CTD)L Schrieber, R N Maini
Bailliere'S Clinical Rheumatology|November 1, 1995
Anti-cytokine therapy in rheumatoid arthritisM J Elliott, R N Maini
Advances in Experimental Medicine and Biology|January 1, 1993
Antibodies to neutrophil cytoplasmic antigens in rheumatoid arthritisP J Charles, R N Maini
Pageof 34

Showing results (11-20 of 337) with videos related to

Sort By:
Pageof 34
Annals of the Rheumatic Diseases|October 22, 2005
The 2005 International Symposium on Advances in Targeted Therapies: what have we learned in the 2000s and where are we going?R N Maini
Rheumatology (Oxford, England)|January 26, 2000
Workshop summary: health outcomes and health economic issues surrounding the use of biological therapies in patients with rheumatoid arthritisR N Maini, F Wolfe
Springer Seminars in Immunopathology|December 4, 1998
Rheumatoid arthritis: introductionM Feldmann, R N Maini
Lancet (London, England)|September 21, 1996
Cytokine therapy in rheumatoid arthritisR N Maini, M Feldmann
Annual Review of Immunology|March 13, 2001
Anti-TNF alpha therapy of rheumatoid arthritis: what have we learned?M Feldmann, R N Maini
International Journal of Clinical Practice|May 16, 2001
Tumour necrosis factor as a therapeutic target in rheumatoid arthritis and other chronic inflammatory diseases: the clinical experience with infliximab (REMICADE)J Bondeson, R N Maini
Rheumatology (Oxford, England)|January 26, 2000
The role of cytokines in the pathogenesis of rheumatoid arthritisM Feldmann, R N Maini
The Netherlands Journal of Medicine|January 1, 1984
Circulating immune complexes (CIC) in connective tissue diseases (CTD)L Schrieber, R N Maini
Bailliere'S Clinical Rheumatology|November 1, 1995
Anti-cytokine therapy in rheumatoid arthritisM J Elliott, R N Maini
Advances in Experimental Medicine and Biology|January 1, 1993
Antibodies to neutrophil cytoplasmic antigens in rheumatoid arthritisP J Charles, R N Maini
Pageof 34